(Q34571349)

3 August 2017

1 reference

18 December 2019

The prevalence and assessment of ErbB2-positive breast cancer in Asia: a literature survey (English)

1 reference

Erb-b2 receptor tyrosine kinase 2

3 August 2017

1 reference

18 December 2019

1 reference

18 December 2019

Yew Oo Tan

1

1 reference

3 August 2017

Sehwan Han

2

1 reference

3 August 2017

Yen-Shen Lu

3

1 reference

3 August 2017

Cheng-Har Yip

4

1 reference

3 August 2017

Patrapim Sunpaweravong

5

1 reference

3 August 2017

Joon Jeong

6

1 reference

3 August 2017

Priscilla B Caguioa

7

1 reference

3 August 2017

Shyam Aggarwal

8

1 reference

3 August 2017

Ee Min Yeoh

9

1 reference

3 August 2017

Hanlim Moon

10

1 reference

3 August 2017

language of work or name

English

0 references

publication date

16 August 2010

1 reference

3 August 2017

1 December 2010

10 references

13 March 2019

3 April 2019

19 June 2019

17 June 2019

31 July 2019

2 August 2019

7 August 2019

28 September 2019

15 December 2019

18 December 2019

11 references

3 August 2017

13 March 2019

3 April 2019

19 June 2019

17 June 2019

31 July 2019

2 August 2019

7 August 2019

28 September 2019

15 December 2019

18 December 2019

116

1 reference

3 August 2017

issue

23

1 reference

3 August 2017

page(s)

5348-5357

1 reference

Creative Commons Attribution 2.5 Generic

3 August 2017

copyright license

10 references

13 March 2019

3 April 2019

19 June 2019

17 June 2019

31 July 2019

2 August 2019

7 August 2019

28 September 2019

15 December 2019

on focus list of Wikimedia project

18 December 2019

ScienceSource

0 references

cites work

Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in Asia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

Targeted therapies in breast cancer: where are we now?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

Prognosis of Japanese breast cancer based on hormone receptor and HER2 expression determined by immunohistochemical staining

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

High-level SLP-2 expression and HER-2/neu protein expression are associated with decreased breast cancer patient survival

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

Clinical observations from a breast cancer registry in Asian women

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

Spectrum of breast cancer in Asian women

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

A phase II randomized study of two taxanes and cisplatin for metastatic breast cancer after anthracycline: a final analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

c-erbB-2 (HER-2/neu) immunohistochemistry in invasive breast cancer: is there concordance between standard sections and tissue microarrays?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

Global cancer statistics, 2002

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

Global trends in breast cancer incidence and mortality 1973-1997.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

Immunohistochemical assay (IHC) to study C-erbB-2 status of breast cancer using monoclonal antibody CIBCgp185.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

Expression of HER-2/NEU oncoprotein in familial and non-familial breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.

7 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25476

High pathologic complete response in HER 2-positive locally advanced breast cancer after primary systemic chemotherapy with weekly docetaxel and epirubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25476

Breast carcinoma in women 35 years and younger: a pathological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25476

Multiple Genetic Polymorphisms of GSTP1 313AG, MDR1 3435CC, and MTHFR 677CC highly correlated with early relapse of breast cancer patients in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25476

HER-2 testing in breast cancer using parallel tissue-based methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25476

Breast cancer in limited-resource countries: diagnosis and pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25476

The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25476

C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

Immunohistochemical study of c-erbB-2 expression in primary breast cancer

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038357

HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20715159

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Over-expression of c-erbB-2 correlates with nuclear morphometry and prognosis in breast carcinoma in Asian women

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20715159

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical validation of a customized multiple signature microarray for breast cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20715159

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/CNCR.25476

1 reference

3 August 2017

1 reference

3 August 2017

1 reference